Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
Public ClinicalTrials.gov record NCT00038454. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Single-Blind, Controlled Clinical Trial to Evaluate the Efficacy and Safety of Hemolink[Tm] (o-Raffinose Cross-Linked Human Hemoglobin) in Subjects Undergoing Primary Coronary Artery Bypass Grafting Surgery
Study identification
- NCT ID
- NCT00038454
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Hemosol
- Industry
- Enrollment
- 180 participants
Conditions and interventions
Conditions
Interventions
- Hemolink (hemoglobin raffimer IV solution) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente Medical Center - San Francisco-Division of Cardiovascular Anesthesia | San Francisco | California | 94115 | — |
| Stanford University Medical Center: Department of Anesthesiology | Stanford | California | 94305 | — |
| Clinical Research Center | Sarasota | Florida | 34239 | — |
| Heart and Vascular Care | Des Moines | Iowa | 50314 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Englewood Hospital | Englewood | New Jersey | 07361 | — |
| Robert Wood Johnson Hospital | New Brunswick | New Jersey | 08901 | — |
| Mount Sinai Medical Center | New York | New York | 10029-6574 | — |
| University of North Carolina: Department of Anesthesiology | Chapel Hill | North Carolina | 27514 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| The Ohio State University Department of Anesthesiology | Columbus | Ohio | 43210 | — |
| Veterans Affairs Medical Center | Portland | Oregon | 97201 | — |
| Legacy Research | Portland | Oregon | 97232 | — |
| UPMC Health System | Pittsburgh | Pennsylvania | 15213 | — |
| Cardiovascular Anesthesia Research:Texas Heart Institute | Houston | Texas | 77225-0345 | — |
| Inova Fairfax Hospital | Falls Church | Virginia | 55042-3300 | — |
| McGuire VA Medical Center | Richmond | Virginia | 23249 | — |
| Medical College of Virginia: Department of Anesthesiology | Richmond | Virginia | 23298-0695 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00038454, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00038454 live on ClinicalTrials.gov.